Trademark: 88338800
Word
OMNIVANCE
Status
Registered
Status Code
700
Status Date
Tuesday, February 16, 2021
Serial Number
88338800
Registration Number
6273428
Registration Date
Tuesday, February 16, 2021
Mark Type
4000
Filing Date
Wednesday, March 13, 2019
Published for Opposition
Tuesday, October 15, 2019

Trademark Owner History
QPEX BIOPHARMA, INC. - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment and prevention of infections and infectious diseases; Antimicrobial preparations for the treatment and prevention of infections and infectious diseases
42 Research and development of pharmaceuticals and antimicrobials

Trademark Events
Feb 16, 2021
Registered-Principal Register
Jan 9, 2021
Notice Of Acceptance Of Statement Of Use E-Mailed
Jan 8, 2021
Allowed Principal Register - Sou Accepted
Dec 17, 2020
Statement Of Use Processing Complete
Dec 7, 2020
Use Amendment Filed
Dec 17, 2020
Case Assigned To Intent To Use Paralegal
Dec 7, 2020
Teas Statement Of Use Received
Jun 10, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 8, 2020
Extension 1 Granted
Jun 8, 2020
Extension 1 Filed
Jun 8, 2020
Teas Extension Received
Dec 10, 2019
Noa E-Mailed - Sou Required From Applicant
Oct 15, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 15, 2019
Published For Opposition
Sep 25, 2019
Notification Of Notice Of Publication E-Mailed
Sep 11, 2019
Approved For Pub - Principal Register
Sep 4, 2019
Teas/Email Correspondence Entered
Sep 3, 2019
Correspondence Received In Law Office
Sep 3, 2019
Teas Response To Office Action Received
May 30, 2019
Notification Of Priority Action E-Mailed
May 30, 2019
Priority Action E-Mailed
May 30, 2019
Priority Action Written
May 22, 2019
Assigned To Examiner
Apr 1, 2019
New Application Office Supplied Data Entered In Tram
Mar 30, 2019
Teas/Email Correspondence Entered
Mar 30, 2019
Correspondence Received In Law Office
Mar 28, 2019
Assigned To Lie
Mar 22, 2019
Teas Voluntary Amendment Received
Mar 16, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24